SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-296926
Filing Date
2018-10-10
Accepted
2018-10-10 17:25:19
Documents
4
Period of Report
2018-10-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d633655d8k.htm 8-K 16051
2 EX-99.1 d633655dex991.htm EX-99.1 15698
3 GRAPHIC g633655ig1.jpg GRAPHIC 3036
4 GRAPHIC g633655ig2.jpg GRAPHIC 4766
  Complete submission text file 0001193125-18-296926.txt   43844
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 181116738
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1